Drug · DIN 02417014
RIVASTIGMINE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 5, 2025; first marketed December 5, 2013.
- Drug Identification Number (DIN)
- 02417014
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Rivastigmine N06DA03
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) | 4.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 4, 2013: NOC 14988New Drug Submission (NDS) · Licensing agreement between two companies
Other DINs named RIVASTIGMINE
- DIN 02416999 · Cancelled Post Market
- DIN 02417006 · Cancelled Post Market
- DIN 02417022 · Cancelled Post Market